medigraphic.com
Organo Oficial de la Sociedad Mexicana de Urología

2009, Number 6

<< Back Next >>

Rev Mex Urol 2009; 69 (6)

Minimally invasive suburethral endoprosthesis for stress urinary incontinence treatment: a new method

De León-Jaén SC, Sierra-Mendoza JM, Vásquez-Delgado L, Martínez-Castro MA, Cortés-Gudiño FJ, Orozco-Bravo A

Language: Spanish
References: 9
Page: 289-291
PDF size: 347.14 Kb.


ABSTRACT

Objective: The objective of the present study was to make a short-term evaluation of a new treatment method for stress urinary incontinence (SUI) caused by intrinsic sphincter deficiency.
Materials and methods: A 2 x 8 cm polypropylene monofilament suburethral endoprosthesis was placed in three female patients. Mean patient age was 59.7 years (41-87 year range) and mean BMI was 30.2 Kg/m2 (19-40Kg/m2 range). All women had been diagnosed with SUI by means of urodynamic study. None had undergone previous surgery and they all completed a symptoms questionnaire. At 12-weeks patient follow-up included urodynamics, physical examination and repeat questionnaire application.
Results: There were good postoperative results in the three patients. Surgery duration was 7-17 minutes. Two of the patients are now continent and one has improved symptomatology. None of the three presented with urine retention, hematoma or bladder injury.
Conclusions: Suburethral endoprosthesis is a safe method that modifies the transobturator system. The present study is a preliminary one that showed initial effectiveness but the authors are aware that further studies, a greater number of patients and a longer follow-up period are necessary in order to corroborate clinical benefit.


REFERENCES

  1. Sánchez-Cañis, Gali-Bielsa. Resultados y complicaciones de la técnica TVT en el tratamiento de la incontinencia de esfuerzo femenina. Actas Urol Esp 2005;29(3):278-91.

  2. Alcaray M, Monga A, Stanton SL. Burch colposuspension: a 10-20 year follow-up. Br J Obstet Gynecol 1995;102(9):740-5.

  3. Ulmsten U, Henriksson L, Johnson P, Varhos G. An ambulatory surgical procedure under local anesthesia for treatment of female urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 1996;7(2):81-5.

  4. Ponce Diaz-Reixa J, Barbagelata-Lopez A, Alvarez-Castelo L, Romero- Salas E. Surgical treatment of stress female incontinence with the SPARC sling. Analysis of our experience. Actas Urol Esp 2007;31(10):1129–33.

  5. Pardo S, Ricci A, Tacla F. Cinta trans-obturadora (OTB) en la corrección de la incontinencia urinaria de esfuerzo. Experiencia de tres años con 200 pacientes. Actas Urol Esp 2007;331(10):1141-47.

  6. Petros PE, Richardson PA. Miduretral tissue fixation system sling-a micromethod for cure of stress incontinence-3 year results. Int Urogynecol J 2008;19:869-71.

  7. Costantini E, Lazzeri M. Managing complication after miduretral sling for stress urinary incontinence. EAU-EBU 2007;5(6):232-40.

  8. ostantini E, Lazzeri M, Giannantoni A. Preoperative valsalva leak point pressure not predict outcome of mid-urethral slings. Analysis forms a randomized controlled trial of retropubic versus transobrturador mid-urethral slings. International Braz J Urol 2008;34(1):73-81.

  9. Nazemi TM, Yamada B, Govier FE. Minimum 24-month follow-up of the sling for the treatment of stress urinary incontinence. J Urol 2008;179(2),596-




2020     |     www.medigraphic.com